IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult

Acta Oncologica

Volumn 48, Issue 3, 2009, Pages 431-439

  Ho, Kean F ^a   Fowler, Jack F ^b   Sykes, Andrew J ^c   Yap, Beng K ^c   Lee, Lip W ^c   Slevin, Nick J ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF WISCONSIN   (United States)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; NIMORAZOLE; PACLITAXEL;

ARTICLE; CANCER CENTER; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; METHODOLOGY; NECK; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STANDARDIZATION; TOXICITY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; HEAD AND NECK TUMOR; MULTICENTER STUDY;

DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 65349166714     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802372272     Document Type: Article

References (27)

1. Allen AM, Tishler RB. Commentary: IMRT for head and neck cancer: Many chapters left to write. Oncologist 2007;/ 12:/565-8.
2. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000;/46:/619.
3. Fowler JF. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling. Clin Oncol 2007;/19:/8.
4. Fowler JF, Harari PM, Leborgne F, Leborgne JH. Acute radiation reactions in oral and pharyngeal mucosa: Tolerable levels in altered fractionation schedules. Radiother Oncol 2003;/69:/161.
5. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;/362(9388):/933-40. (Pubitemid 37159288)
6. Madani I, Duthoy W, Derie C, De Gersem W, Boterberg T, Saerens M, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2007;/ 68:/126-35.
7. Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, Miles EA, et al. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol 2007;/85:/36-41.
8. Guerrero Urbano MT, Clark CH, Kong C, Miles E, Dearnaley DP, Harrington KJ, et al. Target volume definition for head and neck intensity modulated radiotherapy: Pre-clinical evaluation of PARSPORT trial guidelines. Clin Oncol 2007;/19:/604.
9. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 1995;/32:/1227-37.
10. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;/354:/567-78.
11. Elting LS, Isitt J, Murphy BA, Garden AS, Gwede CK, Trotti A, et al. 2428: Retrospective and prospective studies of the severity of Oral Mucositis (OM) in Intensity Modulated Radiation Therapy (IMRT) compared to conventional radiation therapy in head and neck cancer (HNC) patients. Int J Radiat Oncol Biol Phys 2006;/66(3 Suppl 1):/S447.
12. Garden AS, Morrison WH, Wong PF, Tung SS, Rosenthal DI, Dong L, et al. Disease-control rates following intensitymodulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007;/67:/438- 44.
13. Yao M, Chang K, Funk GF, Lu H, Tan H, Wacha J, et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the University of Iowa experience. Int J Radiat Oncol Biol Phys 2007;/67:/ 1332-41.
14. Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004;/233:/93-100.
15. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;/338:/1798-804.
16. Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 2000;/18:/1458- 64.
17. Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004;/22:/4665-73.
18. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;/27:/131-46.
19. Oita M, Ohmori K, Obinata K, Kinoshita R, Onimaru R, Tsuchiya K, et al. Uncertainty in treatment of head-andneck tumors by use of intraoral mouthpiece and embedded fiducials. Int J Radiat Oncol Biol Phys 2006;/64:/1581-8.
20. http://www.rtog.org/members/protocols/0522/0522.pdf.
21. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 2004;/59:/242-9.
22. Apisarnthanarax S, Elliott DD, El-Naggar AK, Asper JA, Blanco A, Ang KK, et al. Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys 2006;/64:/678-83.
23. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol 2006;/24:/2618- 23.
24. Eisbruch A. Intensity-modulated radiation therapy in the treatment of head and neck cancer. Nat Clin Pract Oncol 2005;/2:/34-9.
25. Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005;/63:/410.
26. Hong TS, Tome WA, Chappell RJ, Harari PM. Variations in target delineation for head and neck IMRT: An international multi-institutional study. Int J Radiat Oncol Biol Phys 2004; 60:S157.
27. Das IJ, Cheng CW, Chopra KL, Mitra RK, Srivastava SP, Glatstein E. Intensity-modulated radiation therapy dose prescription, recording, and delivery: Patterns of variability among institutions and treatment planning systems. J Natl Cancer Inst 2008;/100:/300-7.